top-banner

Non-Invasive Prenatal Testing

New generation NIPT for common genetic conditions

SELECT THE RIGHT TEST FOR YOU

With VERACITY and VERAgene, you have the option of taking a highly accurate (>99%) and safe non-invasive prenatal test (NIPT) to check for genetic conditions of the fetus before birth with no risk for miscarriage. In both NIPTs, cell-free DNA from the mother’s blood is analyzed to detect potential changes in the genome including aneuploidies and microdeletions. Additionally, VERAgene tests for single gene (monogenic) disorders in the biological parents. Both tests are recommended for any pregnant women, independent of age and risk category and can be done from 10th week of pregnancy. Choose VERACITY to detect the most common fetal aneuploidies and microdeletions which occur more frequent with advanced maternal age. Choose VERAgene if you additionally want to simultaneously screen for other microdeletions and monogenic diseases that do not have any maternal age-associated risk and can have a significant impact on life quality. The outcome of the test can help parents take informed decisions about possible treatments and clinical management.

VERACITY

Detection of the most common fetal aneuploidies and microdeletions (all included in VERAgene as well) which occur more frequent with advanced maternal age. VERACITY has been validated by several clinical studies for single and twin pregnancies, and can also be used in pregnancies conceived through in-vitro fertilization (IVF).

Learn more

VERAgene

Simultaneous screen for aneuploidies (included in VERACITY), microdeletions and monogenic diseases provides a comprehensive solution to prospective parents using a single test. Genetic diseases screened in VERAgene are associated with significant impact on life quality.

Learn more

Rhesus factor test

With non-invasive fetal Rhesus factor (RhD) determination, RhD negative pregnant women can have their blood tested to determine the RhD of their unborn child.

LATEST ARTICLES

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled …

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation…

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst…

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day …

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo…

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first…

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten …

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the…

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the…

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa…

Read more

OUR NETWORK